Whooping Cough (Pertussis) Vaccine Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Immunogenicity and Safety of Diphtheria, Tetanus, Pertussis (DTaP) Vaccine in 3-month-old Infants
Conditions: Healthy Volunteers Interventions: Biological: Diphtheria, tetanus and acellular pertussis (component) combined vaccine (adsorbed); Biological: Diphtheria, tetanus and acellular pertussis combined vaccine (adsorbed); Biological: Diphtheria, tetanus, pertussis (acellular, component), poliomyelitis (inactivated) vaccine (adsorbed) and Haemophilus influenzae type b conjugate vaccine Sponsors: Beijing Zhifei Lvzhu Biopharmaceutical Co., Ltd Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 3, 2024 Category: Research Source Type: clinical trials

Restoration of Immunity to Vaccine Preventable Diseases After CART-T Cell Therapy
Conditions: Vaccine Immunity in CAR-T Cell Therapy Recipients Interventions: Biological: Vaccines against: Diphtheria, tetanus, pertussis, polio, haemophilus influenza type b, varicella and measles Sponsors: Insel Gruppe AG, University Hospital Bern Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 27, 2024 Category: Research Source Type: clinical trials

Use of Virtual Reality in the Reduction of Pain After the Administration of Vaccines Among Children in Primary Care Centers.
Conditions: Pain; Pediatrics; Vaccination; Virtual Reality Interventions: Device: Pico G2 Virtual Reality Glasses (Pico Interactive Inc), together with an Android AOYODKG tablet; Behavioral: Traditional Distractors; Biological: Triple Viral + Varicella Vaccine at 3 years of age; Biological: Hepatitis A + Diphtheria-Tetanus-Pertussis Vaccine at 6 years of age. Sponsors: Fundacio d ' Investigacio en Atencio Primaria Jordi Gol i Gurina Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 15, 2024 Category: Research Source Type: clinical trials

Safety of Tetanus, Diphtheria, Acellular Pertussis With 5 Acellular Pertussis Components (Tdap5) Vaccination During Pregnancy
Conditions: Pertussis (Whooping Cough) Interventions: Other: Not applicable / database analysis Sponsors: Sanofi Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 14, 2024 Category: Research Source Type: clinical trials

Phase I Clinical Trial of Diphtheria-Tetanus-acellular Pertussis Component Combined Vaccine
Conditions: Diphtheria; Tetanus; Pertussis Interventions: Biological: DTacP (one-dose booster); Biological: DTacP (three-dose primary vaccination); Biological: DT (one-dose booster); Biological: DTaP (one-dose booster); Biological: PENTAXIM (one-dose booster); Biological: DTaP (three-dose primary vaccination); Biological: PENTAXIM (three-dose primary vaccination) Sponsors: Institute of Medical Biology, Chinese Academy of Medical Sciences; Sichuan Center for Disease Control and Prevention Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 28, 2023 Category: Research Source Type: clinical trials

Assessing Interventions to Increase Tdap Acceptance for Non-birthing Partners in Pregnancy
Conditions: Non-birthing Partner Vaccination in Pregnancy; Tdap - Tetanus, Diphtheria and Acellular Pertussis Vaccination; Vaccine Exposure During Pregnancy Interventions: Behavioral: Education; Biological: Vaccine administration Sponsors: Women and Infants Hospital of Rhode Island Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 16, 2023 Category: Research Source Type: clinical trials

Knowledge of Pregnant Women Concerning Pertussis, Vaccination Against Pertussis and Cocooning Strategy
Conditions: Pertussis Interventions: Other: Data collection Sponsors: Universit é de Reims Champagne-Ardenne Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 2, 2023 Category: Research Source Type: clinical trials

A Clinical Trial of Adsorbed Cell-free DPT Vaccine (5-component) (for People Aged 6 Years and Above)
Conditions: Diphtheria; Tetanus; Pertussis Interventions: Biological: Tetanus, Reduced Diphtheria and Acellular Pertussis (Five Components) Combined Vaccine, Adsorbed (Aged 6 Years and Older) (Tdcp); Biological: 23-Valent Pneumococcal Polysaccharide Vaccine（PPV23）; Biological: Diphtheria and Tetanus Combined Vaccine, Adsorbed (DT) Sponsor: CanSino Biologics Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 27, 2023 Category: Research Source Type: clinical trials

A Clinical Trial of Adsorbed Cell-free DPT Vaccine (5-component) (for People Aged 6 Years and Above)
Conditions: Diphtheria; Tetanus; Pertussis Interventions: Biological: Tetanus, Reduced Diphtheria and Acellular Pertussis (Five Components) Combined Vaccine, Adsorbed (Aged 6 Years and Older) (Tdcp); Biological: 23-Valent Pneumococcal Polysaccharide Vaccine （PPV23）; Biological: Diphtheria and Tetanus Combined Vaccine, Adsorbed (DT) Sponsors: CanSino Biologics Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 27, 2023 Category: Research Source Type: clinical trials

Optimising DTwP-containing vaccine infant immunisation schedules (OptImms) — a protocol for two parallel, open-label, randomised controlled trials
DiscussionThese data will provide key data to inform policy decisions on streamlining vaccination schedules in childhood.Trial registrationsISRCTN12240140 (Nepa1, 7th January 2021) and ISRCTN6036654 (Uganda, 17th February 2021). (Source: Trials)
Source: Trials - July 21, 2023 Category: Research Source Type: clinical trials

A Study to Evaluate Safety and Immunogenicity of APV006 in Healthy Adults
Conditions: Diphtheria; Tetanus; Pertussis; Poliomyelitis; Hepatitis B; Haemophilus Influenzae Type b Infection Intervention: Biological: DTaP-HepB-IPV-Hib vaccine Sponsor: LG Chem Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 19, 2023 Category: Research Source Type: clinical trials

A Clinical Trial of Diphtheria, Tetanus and Acellular Pertussis (Three Components) Combined Vaccine, Adsorbed(DTcP)
Condition: Diphtheria, Tetanus and Acellular Pertussis Interventions: Biological: Diphtheria, Tetanus and Acellular Pertussis (Three Components) Combined Vaccine, Adsorbed (DTcP); Biological: Diphtheria，Tetanus and Acellular Pertussis Combined Vaccine，DTaP; Biological: Diphtheria,tetanus,pertussis(acellular,component),Inactivated polio vaccine(adsorbed） and Haemophilus influenzae type b conjugate vaccine,adsorbed,DTaP-IPV-Hib; Biological: DTcP; Biological: DTaP-IPV-Hib Sponsor: CanSino Biologics Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 19, 2023 Category: Research Source Type: clinical trials